• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Menthane monoterpenoids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Monoterpenoids Menthane monoterpenoids
• Natural Products and Extracts Plant Extracts Plant based Hesperozygis rhododon

Recent Advances in the Study of Neomenthyl Acetate (CAS: 2230-87-7) in Chemical Biology and Pharmaceutical Applications

Neomenthyl Acetate (CAS: 2230-87-7) is a derivative of menthol, widely recognized for its applications in the fragrance and flavor industry. Recent studies have expanded its potential into the chemical biology and pharmaceutical sectors, particularly due to its unique stereochemical properties and bioactivity. This research briefing synthesizes the latest findings on Neomenthyl Acetate, focusing on its synthesis, biological activities, and emerging therapeutic applications.

One of the key advancements in the synthesis of Neomenthyl Acetate involves the optimization of catalytic processes to enhance yield and enantiomeric purity. A 2023 study published in the Journal of Organic Chemistry demonstrated a novel enzymatic approach using lipase-catalyzed transesterification, achieving over 95% enantiomeric excess. This method not only improves efficiency but also aligns with green chemistry principles by reducing solvent waste and energy consumption.

In the realm of biological activities, Neomenthyl Acetate has shown promising antimicrobial and anti-inflammatory properties. Research conducted at the University of Tokyo revealed its efficacy against Gram-positive bacteria, including Staphylococcus aureus, with minimal cytotoxicity to human cells. These findings, published in Bioorganic & Medicinal Chemistry Letters, suggest potential applications in topical antiseptics and wound care formulations.

Furthermore, Neomenthyl Acetate has been investigated for its role in drug delivery systems. A 2024 study in the International Journal of Pharmaceutics highlighted its use as a chiral auxiliary in prodrug design, enhancing the bioavailability of poorly soluble active pharmaceutical ingredients (APIs). This innovation could address critical challenges in oral drug delivery, particularly for hydrophobic compounds.

The therapeutic potential of Neomenthyl Acetate extends to neurology, where its structural similarity to menthol has been exploited for modulating TRPM8 ion channels. Preliminary in vitro studies indicate its ability to attenuate neuropathic pain signals, as reported in a recent issue of ACS Chemical Neuroscience. These findings open avenues for developing non-opioid analgesics with reduced side effects.

Despite these advancements, challenges remain in scaling up production and ensuring regulatory compliance for pharmaceutical use. Future research directions include exploring synergistic effects with other terpenoids and conducting in vivo efficacy and safety studies. The integration of computational modeling and high-throughput screening could further accelerate the discovery of novel applications for Neomenthyl Acetate.

In conclusion, Neomenthyl Acetate (CAS: 2230-87-7) represents a versatile compound with expanding relevance in chemical biology and pharmaceuticals. Its optimized synthesis, diverse bioactivities, and therapeutic potential underscore its value as a subject of ongoing research. Continued interdisciplinary collaboration will be essential to fully realize its benefits in drug development and beyond.

• 29066-34-0(menthyl acetate)
• 16409-46-4(2-Isopropyl-5-methylcyclohexyl 3-methylbutanoate)
• 76-49-3(Bornyl acetate)
• 77341-67-4(4-(((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)oxy)-4-oxobutanoic acid)
• 2623-23-6(Menthyl acetate)
• 77-54-3((+)-cedryl acetate)
• 89-48-5((±)-Menthyl Acetate)
• 5726-19-2(2-Methylcyclohexyl Acetate)
• 125-12-2(isobornyl acetate)
• 88-41-5(2-Tert-Butylcyclohexyl acetate)